AHA expresses support for KEEP Telehealth Options Act

Jun 19, 2020 - 03:02 PM
computer-closeup-stethoscope-telehealth

The AHA today expressed support for the Knowing the Efficiency and Efficacy of Permanent (KEEP) Telehealth Options Act of 2020, which would allow the government to study the impact of telehealth during the COVID-19 pandemic and its expanded use. “We greatly appreciate the flexibilities implemented during the public health emergency, as they have allowed hospitals and health systems to care for patients in the comfort and safety of their own homes,” AHA wrote to the bill’s sponsors, Reps. Cynthia Axne, D-Iowa, and Troy Balderson, R-Ohio. In addition, AHA said that “additional data on telehealth uptake and usage is critical to help inform changes that will need to be addressed going forward to ensure patients can continue to access care through telehealth.”

Related News Articles

Headline
CDC releases 2025-26 respiratory disease season outlook
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
OSHA extends comment period on proposal removing remaining COVID-19 emergency temporary standard requirements
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Chairperson's File
Chair File: The OBBBA and What’s Next for Health Care
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…